Advancing Vaccine Innovation at World Vaccine Congress Amsterdam 2025

Vienna, Austria: – Bioprocessing solutions expert enGenes Biotech will share insights into its advanced vaccine development capabilities at the upcoming 2025 World Vaccine Congress in Amsterdam.

The WVC franchise, with annual congresses in Europe and the USA, has become a leading global knowledge-sharing platform for the whole vaccine R&D and manufacturing value chain. enGenes will be an active participant in the many networking events in Amsterdam, detailing the various ways in which it can speed vaccine development.  These include support for development of recombinant protein and plasmid DNA bioprocesses and advanced affinity ligand activities.

Driving vaccine development

enGenes Business Development Manager Dr. Ophelia Gevaert will lead the company’s presence in Amsterdam and welcomes pre-event connections to make appointments for face-to-face meetings (see Resources).

Dr. Gevaert commented: “This important congress provides us with a ‘must attend’ opportunity to exchange ideas and foster collaborations that will drive forward the development of new and effective vaccines.”

Read the full article here: https://www.pharmaceutical-networking.com/engenes-biotech-advancing-vaccine-innovation-at-world-vaccine-congress-amsterdam-2025/?utm_source=dlvr.it&utm_medium=linkedin